Effect of injection laryngoplasty material on outcomes in pediatric vocal fold paralysis.
Vocal cord augmentation
injection laryngoplasty
inter-surgical interval
unilateral vocal cord paralysis
Journal
Translational pediatrics
ISSN: 2224-4344
Titre abrégé: Transl Pediatr
Pays: China
ID NLM: 101649179
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
03
08
2021
accepted:
15
12
2021
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
ppublish
Résumé
While injection laryngoplasty is becoming increasingly common in children, there has not been clearly established guidelines for the choice of injection material. This study evaluates for variability in post-surgical outcomes between different materials used for injection laryngoplasty in the treatment of pediatric unilateral vocal cord paralysis. In this cohort study, a retrospective chart review was performed for all patients undergoing injection laryngoplasty for unilateral vocal cord paralysis at our tertiary-care children's hospital between January 2010 and December 2019. Patients with vocal cord paresis or bilateral vocal cord paralysis were excluded from this study. Demographics, pre- and post-injection clinic visits, and operative reports were reviewed to compare outcomes between injection materials, including the number of injections required, inter-surgical interval, and rate of vocal improvement. Forty-four patients were included in the analysis. Half of the patients were female, and half were male. A total of 97 injections were observed, with 32 patients receiving multiple injections. The mean age at first injection was 7 years. The most common causes of vocal fold paralysis were iatrogenic (n=21, 48%) and idiopathic (n=9, 20%). Thirty-nine percent (n=17) had a history of cardiac surgery. Forty-five percent of injections used Radiesse Neither material choice nor demographic factors were associated with a difference in outcomes following injection laryngoplasty or a change in the inter-surgical interval. Further research is needed to develop standardized protocols for injection laryngoplasty in this population.
Sections du résumé
Background
UNASSIGNED
While injection laryngoplasty is becoming increasingly common in children, there has not been clearly established guidelines for the choice of injection material. This study evaluates for variability in post-surgical outcomes between different materials used for injection laryngoplasty in the treatment of pediatric unilateral vocal cord paralysis.
Methods
UNASSIGNED
In this cohort study, a retrospective chart review was performed for all patients undergoing injection laryngoplasty for unilateral vocal cord paralysis at our tertiary-care children's hospital between January 2010 and December 2019. Patients with vocal cord paresis or bilateral vocal cord paralysis were excluded from this study. Demographics, pre- and post-injection clinic visits, and operative reports were reviewed to compare outcomes between injection materials, including the number of injections required, inter-surgical interval, and rate of vocal improvement.
Results
UNASSIGNED
Forty-four patients were included in the analysis. Half of the patients were female, and half were male. A total of 97 injections were observed, with 32 patients receiving multiple injections. The mean age at first injection was 7 years. The most common causes of vocal fold paralysis were iatrogenic (n=21, 48%) and idiopathic (n=9, 20%). Thirty-nine percent (n=17) had a history of cardiac surgery. Forty-five percent of injections used Radiesse
Conclusions
UNASSIGNED
Neither material choice nor demographic factors were associated with a difference in outcomes following injection laryngoplasty or a change in the inter-surgical interval. Further research is needed to develop standardized protocols for injection laryngoplasty in this population.
Identifiants
pubmed: 35957995
doi: 10.21037/tp-21-361
pii: tp-11-07-1114
pmc: PMC9360818
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1114-1121Informations de copyright
2022 Translational Pediatrics. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-21-361/coif). CE is a consultant for Smith and Nephew and Chief Scientific Officer for Zotarix Inc. The other authors have no conflicts of interest to declare.
Références
Arch Otolaryngol Head Neck Surg. 2011 Mar;137(3):264-8
pubmed: 21422311
Laryngoscope. 2019 Jul;129(7):1699-1705
pubmed: 30353553
Eur Arch Otorhinolaryngol. 2006 Mar;263(3):205-9
pubmed: 16177917
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Mar;30(5):423-6
pubmed: 27382698
Int J Pediatr Otorhinolaryngol. 2019 Feb;117:127-130
pubmed: 30579066
Laryngoscope. 2010 Oct;120(10):2042-6
pubmed: 20824787
Laryngoscope. 1979 Sep;89(9 Pt 1):1378-84
pubmed: 481043
Otolaryngol Head Neck Surg. 2019 Mar;160(3):540-545
pubmed: 30453837
Arch Otolaryngol Head Neck Surg. 2012 Dec;138(12):1161-6
pubmed: 23247235
Curr Opin Otolaryngol Head Neck Surg. 2004 Dec;12(6):538-42
pubmed: 15548914
JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):654-60
pubmed: 25973887